C40H50N2.C23H16O6
Neat
558.86 388.38
-20°C
Room Temperature
Imipramine pamoate; 10075-24-8; Tofranil-PM; Imipramine embonate; MC34P30298; DTXSID80143484; 4, 4'-Methylenebis(3-hydroxy-2-naphthoic) acid, compound with 10, 11-dihydro-N, N-dimethyl-5H-dibenz(b, f)azepine-5-propylamine (1:2); 4, 4'-Methylenebis(3-hydroxy-2-naphthoic acid)-3-(10, 11-dihydro-5H-dibenzo(b, f)azepin-5-yl)-N, N-dimethyl-1-propanamine (1:2); RefChem:57885; DTXCID6065975; 233-206-6; Imipramine (pamoate); 4-[(3-carboxy-2-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylic acid;3-(5, 6-dihydrobenzo[b][1]benzazepin-11-yl)-N, N-dimethylpropan-1-amine; 4, 4'-methylenebis[3-hydroxy-2-naphthoic] acid, compound with 10, 11-dihydro-N, N-dimethyl-5H-dibenz[b, f]azepine-5-propylamine (1; EINECS 233-206-6; UNII-MC34P30298; Tofranil-pm (TN); Imipramine pamoate (USP); 5H-Dibenz(b, f)azepine, 5-(3-(dimethylamino)propyl)-10, 11-dihydro- and pamoate; orb1942691
4-[(3-carboxy-2-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylic acid;bis(3-(5, 6-dihydrobenzo[b][1]benzazepin-11-yl)-N and N-dimethylpropan-1-amine)
InChI=1S/C23H16O6.2C19H24N2/c24-20-16(14-7-3-1-5-12(14)9-18(20)22(26)27)11-17-15-8-4-2-6-13(15)10-19(21(17)25)23(28)29;2*1-20(2)14-7-15-21-18-10-5-3-8-16(18)12-13-17-9-4-6-11-19(17)21/h1-10,24-25H,11H2,(H,26,27)(H,28,29);2*3-6,8-11H,7,12-15H2,1-2H3